The purpose of this study is to determine whether GSK232802 is safe and effective in reducing the frequency and severity of hot flashes associated with menopause.

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

A Parallel-group, Double-blind, Randomized, Placebo-controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Two Doses of GSK232802 Administered Orally as Monotherapy for 12 Weeks in Healthy Postmenopausal Women With Moderate to Extremely Severe Vasomotor Symptoms

Treatment Trials

Focus your search

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Description

Conditions